Letters

I found Dilsaver’s and Coffman’s opinion column on funding for AIDS and psychiatric research (The Scientist, July 11, page 11) both provoking and disturbing. By inviting comparison, debate, and scrutiny between research agendas—perhaps in response to Frank Press’s call (The Scientist, May 30, page 1) to set research priorities within the scientific community—the article provokes useful discussion. Yet by misrepresenting the tragedy of AIDS and by misapprehendin

Written byDavid Guston
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I found Dilsaver’s and Coffman’s opinion column on funding for AIDS and psychiatric research (The Scientist, July 11, page 11) both provoking and disturbing. By inviting comparison, debate, and scrutiny between research agendas—perhaps in response to Frank Press’s call (The Scientist, May 30, page 1) to set research priorities within the scientific community—the article provokes useful discussion. Yet by misrepresenting the tragedy of AIDS and by misapprehending the role of biomedical research in national affairs, the article threatens to disturb the momentum and support for AIDS research and education. Dilsaver and Coffman diminish the tragedy of AIDS by claiming that it “afflicts only 65,000 Americans.” The true scope of AIDS in the United States is represented not by this official count of clinical AIDS but by the one to one and a half million infected by HIV. These numbers, of course, do not include the increasing millions of infected persons ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies